Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ITOS |
---|---|---|
09:32 ET | 8146 | 9.67 |
09:34 ET | 800 | 9.66 |
09:36 ET | 600 | 9.63 |
09:38 ET | 4950 | 9.61 |
09:39 ET | 300 | 9.665 |
09:41 ET | 605 | 9.675 |
09:43 ET | 1123 | 9.68 |
09:45 ET | 3231 | 9.72 |
09:48 ET | 5394 | 9.755 |
09:50 ET | 1100 | 9.76 |
09:52 ET | 1661 | 9.81 |
09:54 ET | 967 | 9.775 |
09:56 ET | 2360 | 9.73 |
09:57 ET | 500 | 9.755 |
09:59 ET | 650 | 9.76 |
10:01 ET | 950 | 9.8 |
10:03 ET | 2933 | 9.74 |
10:06 ET | 100 | 9.735 |
10:08 ET | 3731 | 9.725 |
10:10 ET | 650 | 9.75 |
10:12 ET | 2000 | 9.71 |
10:14 ET | 2205 | 9.745 |
10:15 ET | 800 | 9.76 |
10:17 ET | 500 | 9.77 |
10:19 ET | 750 | 9.79 |
10:21 ET | 1101 | 9.8 |
10:24 ET | 1000 | 9.73 |
10:26 ET | 1650 | 9.7235 |
10:28 ET | 400 | 9.73 |
10:30 ET | 1600 | 9.69 |
10:32 ET | 3524 | 9.705 |
10:35 ET | 300 | 9.745 |
10:37 ET | 250 | 9.751 |
10:39 ET | 200 | 9.765 |
10:42 ET | 100 | 9.75 |
10:44 ET | 850 | 9.75 |
10:46 ET | 100 | 9.74 |
10:48 ET | 800 | 9.76 |
10:50 ET | 1000 | 9.7519 |
10:51 ET | 900 | 9.78 |
10:53 ET | 200 | 9.81 |
11:00 ET | 10199 | 9.86 |
11:02 ET | 855 | 9.87 |
11:04 ET | 1561 | 9.875 |
11:08 ET | 1772 | 9.89 |
11:09 ET | 3352 | 9.925 |
11:11 ET | 600 | 9.88 |
11:13 ET | 1218 | 9.87 |
11:18 ET | 872 | 9.76 |
11:20 ET | 2500 | 9.79 |
11:22 ET | 300 | 9.73 |
11:24 ET | 1400 | 9.7 |
11:26 ET | 1717 | 9.735 |
11:27 ET | 1680 | 9.735 |
11:31 ET | 756 | 9.71 |
11:33 ET | 1200 | 9.7155 |
11:36 ET | 4716 | 9.725 |
11:38 ET | 3896 | 9.725 |
11:40 ET | 958 | 9.7388 |
11:42 ET | 600 | 9.72 |
11:44 ET | 1850 | 9.76 |
11:45 ET | 250 | 9.75 |
11:47 ET | 200 | 9.74 |
11:49 ET | 700 | 9.74 |
11:51 ET | 100 | 9.74 |
11:56 ET | 1000 | 9.75 |
11:58 ET | 1200 | 9.785 |
12:00 ET | 100 | 9.78 |
12:02 ET | 960 | 9.8 |
12:03 ET | 512 | 9.79 |
12:05 ET | 400 | 9.81 |
12:07 ET | 400 | 9.86 |
12:09 ET | 315 | 9.85 |
12:12 ET | 300 | 9.855 |
12:14 ET | 100 | 9.87 |
12:16 ET | 856 | 9.875 |
12:18 ET | 3933 | 9.905 |
12:20 ET | 2003 | 9.86 |
12:21 ET | 514 | 9.84 |
12:23 ET | 550 | 9.84 |
12:25 ET | 1374 | 9.85 |
12:27 ET | 620 | 9.85 |
12:30 ET | 900 | 9.835 |
12:32 ET | 438 | 9.84 |
12:34 ET | 100 | 9.85 |
12:36 ET | 1000 | 9.845 |
12:38 ET | 500 | 9.85 |
12:39 ET | 100 | 9.86 |
12:41 ET | 2125 | 9.8 |
12:45 ET | 2586 | 9.82 |
12:50 ET | 200 | 9.825 |
12:52 ET | 1300 | 9.85 |
12:54 ET | 600 | 9.83 |
12:56 ET | 5700 | 9.84 |
12:57 ET | 500 | 9.845 |
12:59 ET | 900 | 9.805 |
01:01 ET | 100 | 9.8 |
01:03 ET | 4820 | 9.81 |
01:06 ET | 1390 | 9.84 |
01:08 ET | 100 | 9.825 |
01:10 ET | 950 | 9.85 |
01:12 ET | 500 | 9.855 |
01:14 ET | 3004 | 9.865 |
01:15 ET | 690 | 9.87 |
01:17 ET | 200 | 9.875 |
01:19 ET | 100 | 9.87 |
01:21 ET | 950 | 9.8799 |
01:24 ET | 862 | 9.86 |
01:26 ET | 350 | 9.84 |
01:28 ET | 1350 | 9.845 |
01:30 ET | 600 | 9.875 |
01:32 ET | 1054 | 9.85 |
01:33 ET | 1500 | 9.855 |
01:35 ET | 500 | 9.87 |
01:37 ET | 397 | 9.87 |
01:39 ET | 1350 | 9.875 |
01:42 ET | 1400 | 9.9 |
01:44 ET | 806 | 9.915 |
01:48 ET | 300 | 9.91 |
01:50 ET | 1930 | 9.855 |
01:51 ET | 100 | 9.875 |
01:53 ET | 300 | 9.835 |
01:55 ET | 200 | 9.83 |
01:57 ET | 450 | 9.83 |
02:00 ET | 100 | 9.84 |
02:02 ET | 100 | 9.82 |
02:04 ET | 250 | 9.83 |
02:06 ET | 2151 | 9.78 |
02:09 ET | 2000 | 9.785 |
02:11 ET | 100 | 9.79 |
02:13 ET | 2762 | 9.785 |
02:15 ET | 2300 | 9.82 |
02:18 ET | 700 | 9.8 |
02:20 ET | 100 | 9.83 |
02:22 ET | 300 | 9.8259 |
02:24 ET | 200 | 9.84 |
02:26 ET | 520 | 9.88 |
02:27 ET | 158 | 9.8724 |
02:29 ET | 600 | 9.89 |
02:31 ET | 200 | 9.85 |
02:33 ET | 1700 | 9.845 |
02:36 ET | 600 | 9.85 |
02:38 ET | 2056 | 9.905 |
02:40 ET | 5250 | 9.925 |
02:42 ET | 400 | 9.93 |
02:44 ET | 400 | 9.94 |
02:45 ET | 529 | 9.89 |
02:47 ET | 200 | 9.92 |
02:51 ET | 200 | 9.92 |
02:54 ET | 600 | 9.93 |
02:56 ET | 700 | 9.94 |
02:58 ET | 400 | 9.94 |
03:00 ET | 200 | 9.98 |
03:02 ET | 952 | 9.93 |
03:03 ET | 100 | 9.93 |
03:05 ET | 600 | 9.95 |
03:07 ET | 1444 | 10 |
03:09 ET | 1435 | 10.01 |
03:12 ET | 450 | 10.01 |
03:14 ET | 1944 | 9.99 |
03:16 ET | 350 | 9.995 |
03:18 ET | 100 | 9.995 |
03:20 ET | 1702 | 9.99 |
03:23 ET | 1300 | 10.045 |
03:25 ET | 639 | 10.035 |
03:27 ET | 300 | 10.036 |
03:30 ET | 3898 | 10.055 |
03:32 ET | 1476 | 10.07 |
03:34 ET | 6435 | 10.01 |
03:36 ET | 4523 | 10.06 |
03:38 ET | 2196 | 10.0225 |
03:39 ET | 1488 | 10.02 |
03:41 ET | 400 | 10.02 |
03:43 ET | 2015 | 10.015 |
03:45 ET | 500 | 10.0099 |
03:48 ET | 2101 | 10.005 |
03:50 ET | 1300 | 10.005 |
03:52 ET | 2800 | 9.98 |
03:54 ET | 1069 | 9.985 |
03:56 ET | 5989 | 9.995 |
03:57 ET | 6128 | 10.005 |
03:59 ET | 90878 | 10.02 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Iteos Therapeutics Inc | 365.9M | -3.3x | --- |
MeiraGTx Holdings PLC | 320.3M | -2.8x | --- |
Verve Therapeutics Inc | 423.1M | -1.9x | --- |
C4 Therapeutics Inc | 373.0M | -2.8x | --- |
Taysha Gene Therapies Inc | 411.9M | -2.2x | --- |
Biomea Fusion Inc | 379.5M | -2.7x | --- |
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug, also known as EOS-448/GSK4428859A, is an antagonist of TIGIT, an immune checkpoint with multiple mechanisms of action. Its advanced program is inupadenant, also known as EOS-850, a next-generation adenosine 2A receptor (A2AR) antagonist tailored to overcome the specific adenosine-mediated immunosuppression found in the tumor microenvironment. Its program to initiate clinical trials is EOS-984, a potentially first-in-class small molecule focused on a new mechanism in the adenosine pathway by targeting equilibrative nucleoside transporter 1 (ENT1), a dominant transporter of adenosine on lymphocytes involved in T cell metabolism.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $365.9M |
---|---|
Revenue (TTM) | $35.0M |
Shares Outstanding | 36.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.36 |
EPS | $-3.00 |
Book Value | $16.05 |
P/E Ratio | -3.3x |
Price/Sales (TTM) | 10.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -413.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.